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Purpose: The aim of this work was to demonswate that the exorbital rat 
lacrimal gland was a site of synthesis of some growth factors of the EGF 
family (EGF, HB-EGF, TGFa) and their receptor, namely the EGF receptor 
,FGFP\ \ --. . . , 
Methods: Male Sprague Dawley rats were used in these experhnents. RT- 
PCR and Northern-Blot analysis of the lacrimal gland mRNA population were 
pe~fotmcd to study the expression of both growth factors sod EGFR genes. 
The DKS~WX of EGF-like activities in the soluble fraction of the lacrimal eland 
was’analysed by radio-receptor assay (RRA) using the rat liver EGFR as 
binding unit and moose t?sI-EGF as radioligand. 
The presence of the EGFR protein was .issessed by: 
I/ Immunochemical techniques: immuooprecipiration sod Westem-blot analysis 
of solubilized membrtuie proteins using a specific Sheep polyclonal antibody 
directed against the human EGFR. Its activation by EGF was measulrd using a 
specific mouse moooclonal (4GlO) antrbody directed against phosphotyrosine 
residues 
21 Radioligand binding experiments which were performed on membrane 
fractions usinr ‘?sI-EGF as a radiolinalld 
M Res& demonstrate that thi mRNA population extracted from the rat 
lacrimal gland contains specific transcripts coding for growth factors such as 
EGF, TGFn and HB-EGF as well as for the EGFR. EGF-like growth factors 
were detected by RRA in the soluble fraction sod an EGF activable EGFR 
found in the membrane fraction of the lacrimal gland. 
blusion; The rat exorbital lacrimal gland LS a site of synthesis and a 
potential site of secretion of EGF-like growth factors. These growth factors 
may be released in tears and act to mairitain the comeal epithelium integrity 
and/or act in a paracrioe manner through the activation of the lacrimal cells 
EGFR. Both of these hypothesis have now to be analyscd 
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ASSESSMENT OF OCULAR REAC I IOkS TO DAlrrDtH IN A CAT 
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m To evaluate ocular tindings upon uxposure to cat dander m a 
controlled environment cat room and IO deternlme the efficacy of topical 
kelorolac and oral tedenadme In this model. 
&&& Forty patients with kflOWf1 cat ailtrrgles were 6XpOSed 10 car 
dander for 90 minutes Muiriplo sy~ns and symptoms were evaluilled 
every 36 minutes using quostionnoires. slit lamp exammation. and 
pulmonary function testmg At least one week later, patients were 
randomized to three days of Ireaiment with eilhor 1) placebo drops Ulo 
and oral placebo BID, 2) xetorolnc drops QID and oral placebo BID, 3) 
plac8bo drops QID and oral lerfenidine BlD,4) ketorobc drops OID ar’d 
oral terfenadine BID, or ; this pre treatmerIt was followed by repeat 
exposure 10 cat dander. Data were analyzed by ono-way ANOVA. 
&&)& Cat-sensdive individuals consislently axhlblted signs and 
symptoms of allergy in rhe cat room. Group 2 (Kctorolac drops with oml 
placebo) experienced a greater reduction of ocular itching than the 
other groups (p=O.OS). Group 4 (Ketorolac drops with oral terierladine) 
also showed improvement in ocula: signs and symptoms, but did nor 
achieve statistical signiltcance bucluse ot low sublocI numbers. IWO 
patients were dismissed due to excessive systen~ic signs or symplot~ 
-W The cat room is a safe, reliable. and repmduclble method 
lo challenge the eyes of cat-sensitlvo individuals. Keiorolac showed a 
benebcial effect in controllmg ocular ilching. Ketorolac ana terienadme 
also improved patients signs and symptoms This is an elfeaive mu&l 
for studying oCu!ar aliergic tesponses and drug intorvenbon. 
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